400 mg Imatinib Tablets IP

We have emerged as the prominent organization engaged in offering 400 mg Imatinib Tablets IP. These tablets work by slowing or stopping the growth of cancer cells. We are offering these tablets in diverse packaging options in accordance with customer’s choices. Our offered 400 mg Imatinib Tablets IP are demanded to treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers and disorders of the blood cells.